Standardized planning

Home / Standardized Planning

Beike Biostandardization

Beike Biotechnology is the first enterprise in China to introduce the concept of quality management in the field of cell biomedicine, and carried out the ISO9001 quality management system certification for the first time in 2010, and completed the three-in-one certification of “quality, environment, occupational health and safety” in 2012. At the same time, Beike Biotech Jiangsu Branch is the first company in Chinese mainland to introduce and pass the “Association for the Advancement of Blood & Biological Therapy” (Association for the Advancement of Blood & Biotherapies, abbreviated as AABB, formerly the American Association of Blood Banks). In May 2017, the four autologous cell storage and application technology quality management systems of Beike Biotech Shenzhen Cell Bank (Shenzhen Comprehensive Cell Bank) (Shenzhen Comprehensive Cell Bank) passed the AABB certification at the same time, marking that Beike Biotech has established an integrated technical management model for cell preparation, storage and clinical transformation application services.

The development trajectory of Beike biological standardization construction

Beike certification milestones

From 2005 to 2013, the initial construction and growth of standardization 1

  • ★  Establish enterprise technical standards and introduce international and domestic advanced standardized management standards
  • — In 2010, Beike Biotech carried out the ISO9001 quality management system certification for the first time
  • — In 2012, the integrated system of Beike Biotechnology completed the three-in-one certification of “quality, environment, occupational health and safety”.
  • — In 2011, Beike Biotech Jiangsu Branch introduced the AABB certification system into Chinese mainland and passed its umbilical cord blood and umbilical cord mesenchymal stem cell certification.

From 2014 to 2017, the standardization system developed rapidly 2

  • ★ Standardization research institutions are invited to guide
  • — Establish an internal standardization team
  • — Improve the enterprise standardization management system
  • ★ AABB Cell Therapy Product System Certification
  • — In 2016, the Shenzhen local standard “Code for the Construction and Management of Cell Preparation Center” (No. SZDB/Z 188-2016), which was jointly drafted by Beike Biotechnology and Shenzhen Institute of Standards and Technology, was officially released
  • — In 2017, the Shenzhen local standard “Code for the Construction and Management of Comprehensive Cell Banks” (No. SZDB/Z 266-2017), jointly drafted by Beike Biotechnology and Shenzhen Institute of Standards and Technology, was officially released
  • ★  Employed as the first batch of experts in Shenzhen Standard Library

2018-2019 New developments under the new Standardization Law 3

  • ★ Standardization construction has been recognized
  • — In 2019, Beike Biotech won the honor of “Standardization and Innovation Synchronous Demonstration Enterprise” in Shenzhen
  • — In 2020, Beike Biotech won the title of “2019 Standardization Innovation Demonstration Base”.
  • ★ Prepare for the establishment of associations in the industry
  • — In 2019, in order to promote industry collaboration and standardization, the China Maternal and Child Health Association and the National and Local Joint Engineering Laboratory of Individualized Cell Therapy Technology jointly initiated the establishment of the “China Maternal and Child Health Association Maternal and Child Biosample and Bioinformatics Data Research and Application Branch”

Since 2020, the standardization system has been gradually improved 4

  • ★ Participate in the construction of group standards
  • — 2021, Beike Biosciences participated in the compilation of the group standard of the Chinese Association of Research Hospitals: General Requirements for Laboratory Human Stem Cell Detection (T/CRHA 003—2021)
  • — In 2022, Beike Biotech participated in the compilation of the group standard of the China Pharmaceutical Biotechnology Association: Informed Consent Specification for Stem Cell Donors (T/CMBA019-2022)
  • ★  Participate in the construction of national standards
  • — In 2023, Beike Biotech participated in the formulation of the national standard: GB/T 42398-2023 “Technical Specification for Cell Culture Cleanroom Design” was officially released
  • ★ Assist in the review of various standards in the industry
  • ★ Conduct industry standardization research and make suggestions for the development of the industry
  • ★ Dr. Hu Junyuan, Chairman of Beike Biotechnology, won the 9th “Shenzhen Quality Strong City Gold Medal”

Ongoing efforts

By benchmarking advanced standards and participating in certification, the company's service/product quality improvement is realized

International and domestic dual authentication

AABB Accreditation

AABB certification means that the storage institution has met international standards in cell processing, storage and distribution, and the cells stored in this cell bank have obtained “international certification”

Three-standard integrated certification system

Third-party independent testing organization

Beike Biotech takes the initiative to introduce the cell storage platform of a third-party cell quality testing laboratory to issue a legally effective test report for each tested cell

Work together to build a standardized construction in the cell field

Lead/participate in the construction of standardization

  • Standard type

    A landmark in Shenzhen

  • Standard name

    Cell preparation center construction and management standards

  • Standard number

    SZDB/Z 188-2016

  • Progress

    Published

  • Standard type

    A landmark in Shenzhen

  • Standard name

    Comprehensive cell bank setup and management practices

  • Standard number

    SZDB/Z 266-2017

  • Progress

    Published

  • Standard type

    A landmark in Shenzhen

  • Standard name

    Technology and management standards for the transportation of live human samples

  • Standard number

    DB4403/T 120—2020

  • Progress

    Published

  • Standard type

    A landmark in Shenzhen

  • Standard name

    Transportation technology and management specifications for human cell products

  • Standard number

    DB4403/T 121—2020

  • Progress

    Published

  • Standard type

    Hebei landmark

  • Standard name

    Cell preparation center construction and management standards

  • Standard number

    DB 13/T 5162—2019

  • Progress

    Published

  • Standard type

    Hebei landmark

  • Standard name

    Comprehensive cell bank construction and management standards

  • Standard number

    DB 13/T 5163—2019

  • Progress

    Published

  • Standard type

    Group standards

  • Standard name

    Specification for Informed Consent of Stem Cell Donors (China Association of Pharmaceutical Biotechnology)

  • Standard number

    T/CMBA019-2022

  • Progress

    Published

  • Standard type

    Group standards

  • Standard name

    Specification of Human Umbilical Cord-derived Mesenchymal Stem Cell Preparations for Clinical Research (Shenzhen Cell Therapy Association)

  • Standard number

    SZTT/SSCT 002-2018

  • Progress

    Published

  • Standard type

    Group standards

  • Standard name

    General Requirements for Laboratory Human Stem Cell Testing (Chinese Association of Research Hospitals)

  • Standard number

    T/CRHA 003—2021

  • Progress

    Published

  • Standard type

    National standards

  • Standard name

    Technical specifications for cell culture cleanroom design

  • Standard number

    GB/T 42398-2023

  • Progress

    Published

Suggestions for industry standardization

1
  • Title

    Stem cell industry development research report 2019

  • Published journal or publisher

    National and Local Joint Engineering Laboratory of Individualized Cell Therapy Technology, National High-end Think Tank - China (Shenzhen) Comprehensive Development Research Institute

2
  • Title

    Translation of the Standards of Cell Therapy Services (9th Edition).

  • Published journal or publisher

    China Research Hospital, 2020, 7(5):35.

3
  • Title

    Comparative analysis of quality control standards for umbilical cord blood hematopoietic stem cells in the United States

  • Published journal or publisher

    China Standardization, 2021(16):85-89.

4
  • Title

    The enlightenment of the evaluation of standard innovation demonstration base to the improvement of group standard quality

  • Published journal or publisher

    China Journal of Standardization, 16(2021):85-89.

5
  • Title

    Research progress in stem cell standardization

  • Research progress in stem cell standardization

    Chin J Biologics, 2022, 35(9):7.

6
  • Title

    From the perspective of standardization, the development of cell therapy industry in China is viewed

  • Published journal or publisher

    China Standardization,2023(7):53-60.

Standardization cooperation

Authorities-in-charge: Quality Management Department, Quality Engineering Group

Ms. Lee

Head of Standardization

[email protected]

Mr. Yang

Head of Standardization

[email protected]